Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Justin Moore

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2022
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases PharmacistsKelli A Cole, Anna Y Zhou, Travis Jones, et al.
Journal of General Internal Medicine|April 26, 2022
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort StudyEn-Ling Wu, Rebecca N Kumar, W Justin Moore, et al.
Infection Control and Hospital Epidemiology|June 23, 2025
<i>Candida auris</i> outbreak in a cardiothoracic transplant intensive care unit: implications for infection prevention practices and keeping pace with an evolving landscapeShardul N Rathod, Grace Barajas, Brooks I Mitchell, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2022
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases PharmacistsKelli A Cole, Anna Y Zhou, Travis Jones, et al.
Journal of General Internal Medicine|April 26, 2022
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort StudyEn-Ling Wu, Rebecca N Kumar, W Justin Moore, et al.
Infection Control and Hospital Epidemiology|June 23, 2025
<i>Candida auris</i> outbreak in a cardiothoracic transplant intensive care unit: implications for infection prevention practices and keeping pace with an evolving landscapeShardul N Rathod, Grace Barajas, Brooks I Mitchell, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 2